Operability and safety of the newly developed automated peritoneal dialysis End-stage renal disease (ESRD) Continuous ambulatory peritoneal dialysis (CAPD) Automated peritoneal dialysis (APD)
Conditions
Interventions
Investigate the safety and operability of a newly developed automated peritoneal dialysis.
Experimental Device
Automated Peritoneal Dialysis Machine
Sponsors
National Science and Technology Development Agency (NSTDA)
Eligibility
Sex/Gender
All
Age
20 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. ESRD patient already treated with automated peritoneal dialysis machine 2. Age 20-90 3. Good consciousness with effective verbal communication
Exclusion criteria
Exclusion criteria: 1. Patient with active major cardiovascular diseases 2. Hospitalized with any medical conditions within 3 months before the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety of the newly developed automated peritoneal dialysis Before and after 7-day of treatment Adverse events during testing and comparison of BUN and Creatinine | — |
Secondary
| Measure | Time frame |
|---|---|
| Operability of the newly developed automated peritoneal dialysis During the test Patient and nurse report using the interview questionnaire | — |
Countries
Thailand
Contacts
Public ContactOpas Traitanon
Thammasat University Hospital
Outcome results
None listed